Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6653526

Title:Transgenic mice exhibiting increased susceptibility to seizures
Inventors:Leviten, Michael W.; Palo Alto, CA, USA
Summary:This invention describes an isolated mouse cell whose genome comprises a disruption in a nucleic acid sequence. The resulting transgenic mouse exhibits mutations in a ubiquitin-specific protease 16 gene, which are useful mutations in the modeling of certain diseases and for identifying agents that modulate gene expression and gene function, and as potential treatments for various disease states and disease conditions.
Abstract:The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising mutations in a ubiquitin-specific protease 16 gene. Such transgenic mice are useful as models for disease and for identifying agents that modulate gene expression and gene function, and as potential treatments for various disease states and disease conditions.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6653526
Application Number:US2001000904198
Date Filed:11/07/2001
Date Published:25/11/2003
Assignee:Deltagen, Inc., Redwood, CA, USA


 
Copyright © 2007 The Institute for Cellular Medicine  8/13/2020